Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00165581 · ClinicalTrials.gov registry record · NA
High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma
A NA study, sponsored by Dana-Farber Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00165581 is a NA study that was terminated before completion, run by Dana-Farber Cancer Institute. The registered enrollment target is 15 participants.
The verdict
NCT00165581, a NA study, was terminated before completion, sponsored by Dana-Farber Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the side effects (skin reaction, infection and abscess formation) at the site of radiation treatment, which my occur during the treatment and following 2 months using a new method of radiation therapy for breast cancer.
Interventions
- DEVICE High Dose Intracavitary Brachytherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2002-12 |
| Est. Completion | 2006-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00165581
The ClinicalTrials.gov registry entry for NCT00165581 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which High Dose Intracavitary Brachytherapy is the first listed.
NCT00165581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00165581 about?
NCT00165581 is a clinical study titled "High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma". The purpose of this study is to understand the side effects (skin reaction, infection and abscess formation) at the site of radiation treatment, which my occur during the treatment and following 2 months using a new method of radiation therapy for breast cancer.
What is the current status of trial NCT00165581?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2002-12. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00165581?
The interventions under investigation include: High Dose Intracavitary Brachytherapy (DEVICE).
Who is sponsoring clinical trial NCT00165581?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.